Mitochondrial Proteostasis Links Diabetes and Sarcopenia: Cross-Scale Convergence from Experimental Models to Human Multi-Omics
Diabetes & Metabolism Journal · 2026
DOI: 10.4093/dmj.2026.0310 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, 2026. Verfasst von Shibo Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea. Hauptthemen laut MEDLINE: Proteostasis, Sarcopenia, Diabetes Mellitus, Type 2, Mitochondria. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute, Ministry of Health and Welfare.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Sarcopenia in type 2 diabetes mellitus is increasingly recognized as a mechanistic consequence of chronic metabolic stress rather than mere age-related comorbidity. This review synthesizes evidence demonstrating how insulin resistance, hyperglycemia, lipotoxicity, and inflammation converge on skeletal muscle mitochondrial proteostasis to drive progressive decline. We evaluate seven pathway modules—mitochondrial dynamics, mitophagy, biogenesis, oxidative phosphorylation, nicotinamide adenine dinucleotide (NAD+)/sirtuin (SIRT)-linked regulation, protein import, and the mitochondrial unfolded protein response (UPRmt)—across an evidence map encompassing basic, clinical, and multi-omics studies. Dynamics and mitophagy represent mechanistically central quality-control nodes; their impairment permits dysfunctional organelle accumulation and promotes atrophic cascades. Direct evidence density, however, remains weighted toward oxidative phosphorylation and mitochondrial biogenesis. NAD+/SIRT-linked regulation, protein import fidelity, and UPRmt represent mechanistically upstream but comparatively underinvestigated signals. We propose a diabetes-centered framework where mitochondrial proteostasis failure mediates atrophy and reinforces insulin resistance via a self-amplifying feed-forward loop, supported by pathway responsiveness to coherent interventions. Human multi-omics data highlight network-level dysregulation rather than isolated defects, underscoring module-based biomarker strategies. Translationally, exercise remains the mechanistic cornerstone, while pathway-directed adjuncts—NAD+ precursor repletion, mitophagy modulators, and emerging pharmacotherapeutics—are warranted for patients with identifiable module-specific failure patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea. dryu@gist.ac.kr.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Korea. cmoh@gist.ac.kr.
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Wei, S., Shin, S., Ryu, D., & Oh, C. M. (2026). Mitochondrial Proteostasis Links Diabetes and Sarcopenia: Cross-Scale Convergence from Experimental Models to Human Multi-Omics. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2026.0310
Vancouver
Wei S, Shin S, Ryu D, Oh CM. Mitochondrial Proteostasis Links Diabetes and Sarcopenia: Cross-Scale Convergence from Experimental Models to Human Multi-Omics. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2026.0310
BibTeX
@article{Wei2026,
author = {Wei, Shibo and Shin, Soyeon and Ryu, Dongryeol and Oh, Chang-Myung},
title = {Mitochondrial Proteostasis Links Diabetes and Sarcopenia: Cross-Scale Convergence from Experimental Models to Human Multi-Omics},
journal = {Diabetes & Metabolism Journal},
year = {2026},
doi = {10.4093/dmj.2026.0310}
}
EUVIMED